Global Tigecycline for Injection 麻豆原创 Growth 2025-2031

Publication ID:

LPI02255782

Publication Date:

February 28, 2025

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Tigecycline for Injection market size is predicted to grow from US$ 61.3 million in 2025 to US$ 90.1 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
The 鈥淭igecycline for Injection Industry Forecast鈥� looks at past sales and reviews total world Tigecycline for Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Tigecycline for Injection sales for 2025 through 2031. With Tigecycline for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tigecycline for Injection industry.
This Insight Report provides a comprehensive analysis of the global Tigecycline for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tigecycline for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Tigecycline for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tigecycline for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tigecycline for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Tigecycline for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Original Drug
Generic Drug
Segmentation by Application:
Hospital
Clinic
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Hansoh
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
Jiangsu Aosaikang Pharmaceutical Co.,Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tigecycline for Injection market?
What factors are driving Tigecycline for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tigecycline for Injection market opportunities vary by end market size?
How does Tigecycline for Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Tigecycline for Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tigecycline for Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tigecycline for Injection by Country/Region, 2020, 2024 & 2031
2.2 Tigecycline for Injection Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Tigecycline for Injection Sales by Type
2.3.1 Global Tigecycline for Injection Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Tigecycline for Injection Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Tigecycline for Injection Sale Price by Type (2020-2025)
2.4 Tigecycline for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Other
2.5 Tigecycline for Injection Sales by Application
2.5.1 Global Tigecycline for Injection Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Tigecycline for Injection Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Tigecycline for Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Tigecycline for Injection Breakdown Data by Company
3.1.1 Global Tigecycline for Injection Annual Sales by Company (2020-2025)
3.1.2 Global Tigecycline for Injection Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Tigecycline for Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Tigecycline for Injection Revenue by Company (2020-2025)
3.2.2 Global Tigecycline for Injection Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Tigecycline for Injection Sale Price by Company
3.4 Key Manufacturers Tigecycline for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tigecycline for Injection Product Location Distribution
3.4.2 Players Tigecycline for Injection Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Tigecycline for Injection by Geographic Region
4.1 World Historic Tigecycline for Injection 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Tigecycline for Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tigecycline for Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tigecycline for Injection 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Tigecycline for Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tigecycline for Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tigecycline for Injection Sales Growth
4.4 APAC Tigecycline for Injection Sales Growth
4.5 Europe Tigecycline for Injection Sales Growth
4.6 Middle East & Africa Tigecycline for Injection Sales Growth
5 Americas
5.1 Americas Tigecycline for Injection Sales by Country
5.1.1 Americas Tigecycline for Injection Sales by Country (2020-2025)
5.1.2 Americas Tigecycline for Injection Revenue by Country (2020-2025)
5.2 Americas Tigecycline for Injection Sales by Type (2020-2025)
5.3 Americas Tigecycline for Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tigecycline for Injection Sales by Region
6.1.1 APAC Tigecycline for Injection Sales by Region (2020-2025)
6.1.2 APAC Tigecycline for Injection Revenue by Region (2020-2025)
6.2 APAC Tigecycline for Injection Sales by Type (2020-2025)
6.3 APAC Tigecycline for Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tigecycline for Injection by Country
7.1.1 Europe Tigecycline for Injection Sales by Country (2020-2025)
7.1.2 Europe Tigecycline for Injection Revenue by Country (2020-2025)
7.2 Europe Tigecycline for Injection Sales by Type (2020-2025)
7.3 Europe Tigecycline for Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tigecycline for Injection by Country
8.1.1 Middle East & Africa Tigecycline for Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tigecycline for Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Tigecycline for Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Tigecycline for Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tigecycline for Injection
10.3 Manufacturing Process Analysis of Tigecycline for Injection
10.4 Industry Chain Structure of Tigecycline for Injection
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tigecycline for Injection Distributors
11.3 Tigecycline for Injection Customer
12 World Forecast Review for Tigecycline for Injection by Geographic Region
12.1 Global Tigecycline for Injection 麻豆原创 Size Forecast by Region
12.1.1 Global Tigecycline for Injection Forecast by Region (2026-2031)
12.1.2 Global Tigecycline for Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tigecycline for Injection Forecast by Type (2026-2031)
12.7 Global Tigecycline for Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Tigecycline for Injection Product Portfolios and Specifications
13.1.3 Pfizer Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Sino Biopharmaceutical
13.2.1 Sino Biopharmaceutical Company Information
13.2.2 Sino Biopharmaceutical Tigecycline for Injection Product Portfolios and Specifications
13.2.3 Sino Biopharmaceutical Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sino Biopharmaceutical Main Business Overview
13.2.5 Sino Biopharmaceutical Latest Developments
13.3 Zhejiang Hisun Pharma
13.3.1 Zhejiang Hisun Pharma Company Information
13.3.2 Zhejiang Hisun Pharma Tigecycline for Injection Product Portfolios and Specifications
13.3.3 Zhejiang Hisun Pharma Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zhejiang Hisun Pharma Main Business Overview
13.3.5 Zhejiang Hisun Pharma Latest Developments
13.4 Hansoh
13.4.1 Hansoh Company Information
13.4.2 Hansoh Tigecycline for Injection Product Portfolios and Specifications
13.4.3 Hansoh Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Hansoh Main Business Overview
13.4.5 Hansoh Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Tigecycline for Injection Product Portfolios and Specifications
13.5.3 Abbott Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 Natco Pharma
13.6.1 Natco Pharma Company Information
13.6.2 Natco Pharma Tigecycline for Injection Product Portfolios and Specifications
13.6.3 Natco Pharma Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Natco Pharma Main Business Overview
13.6.5 Natco Pharma Latest Developments
13.7 Lyka Labs Limited
13.7.1 Lyka Labs Limited Company Information
13.7.2 Lyka Labs Limited Tigecycline for Injection Product Portfolios and Specifications
13.7.3 Lyka Labs Limited Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lyka Labs Limited Main Business Overview
13.7.5 Lyka Labs Limited Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Tigecycline for Injection Product Portfolios and Specifications
13.8.3 Fresenius Kabi Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Sandoz
13.9.1 Sandoz Company Information
13.9.2 Sandoz Tigecycline for Injection Product Portfolios and Specifications
13.9.3 Sandoz Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sandoz Main Business Overview
13.9.5 Sandoz Latest Developments
13.10 APOTEX
13.10.1 APOTEX Company Information
13.10.2 APOTEX Tigecycline for Injection Product Portfolios and Specifications
13.10.3 APOTEX Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 APOTEX Main Business Overview
13.10.5 APOTEX Latest Developments
13.11 Accord Healthcare
13.11.1 Accord Healthcare Company Information
13.11.2 Accord Healthcare Tigecycline for Injection Product Portfolios and Specifications
13.11.3 Accord Healthcare Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Accord Healthcare Main Business Overview
13.11.5 Accord Healthcare Latest Developments
13.12 Amneal Pharmaceuticals
13.12.1 Amneal Pharmaceuticals Company Information
13.12.2 Amneal Pharmaceuticals Tigecycline for Injection Product Portfolios and Specifications
13.12.3 Amneal Pharmaceuticals Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Amneal Pharmaceuticals Main Business Overview
13.12.5 Amneal Pharmaceuticals Latest Developments
13.13 Jiangsu Aosaikang Pharmaceutical Co.,Ltd.
13.13.1 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Company Information
13.13.2 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Tigecycline for Injection Product Portfolios and Specifications
13.13.3 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Tigecycline for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Main Business Overview
13.13.5 Jiangsu Aosaikang Pharmaceutical Co.,Ltd. Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.